Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 09, 2023  2 months, 13 hours, 16 minutes ago

Tuberculosis-TB News: Tuberculosis Resurgence in New York City Sparks Urgent Public Health Concerns. Over 500 Cases Detected Amidst City’s Unpreparedness!

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Tuberculosis-TB News: Tuberculosis Resurgence in New York City Sparks Urgent Public Health Concerns. Over 500 Cases Detected Amidst City’s Unpreparedness!
Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 09, 2023  2 months, 13 hours, 16 minutes ago
Tuberculosis-TB News: New York City, often considered the epicenter of innovation, diversity, and opportunity, is facing an unexpected and alarming challenge in 2023. The city, which has historically been a beacon of hope for countless individuals from around the world, is now grappling with a resurgence of tuberculosis (TB) cases. The preliminary data reveals a dramatic increase, with over 500 active TB cases reported in the city during the first part of the year. This marks a staggering 20% rise compared to the same period in the previous year, making 2023 the worst year for TB infections in a decade. This concerning trend has raised questions about the city's preparedness to combat this deadly infectious disease. Experts believe that the actual number of TB infections in the city could be as a high as a few thousand but many are yet to be detected or identified plus many are mistaking some of the symptoms to be that of other respiratory infections including COVID-19. Experts told Tuberculosis-TB News reporters from TMN that it should be noted that already COVID-19 infections are causing many concerning post-COVID conditions including lung fibrosis and dysfunctional immune systems and in some cases some are suffering from COVID-19 induced immunodeficiency and also the SARS-CoV-2 is also able to reactivate dormant TB infections.

The Rising Threat of Tuberculosis
Tuberculosis, often abbreviated as TB, is an infectious respiratory disease caused by the bacterium Mycobacterium tuberculosis. It is primarily transmitted through the air when an infected person coughs, sneezes, talks, or sings. The disease can manifest with various symptoms, which typically include coughing (sometimes accompanied by blood), chest pain, fever, chills, night sweats, and unintentional weight loss. While TB can be effectively treated with antibiotics, untreated cases can lead to severe illness and death. In fact, TB continues to claim the lives of approximately 1.5 million people each year worldwide.
Historical Perspective: The Battle Against TB
The resurgence of TB in New York City is not merely an isolated incident but reflects broader challenges faced in the United States and around the world. It is important to understand the historical context and the significant strides made in the battle against this ancient disease.

Tuberculosis was once one of the deadliest diseases in the world, with recorded cases dating back to the dawn of human history. It remained a formidable foe until the 1900s when the discovery of antibiotics such as streptomycin and para-aminosalicylic acid revolutionized its treatment. This marked a turning point in the fight against TB.
In the early 1990s, New York City was at the epicenter of a nationwide TB epidemic. The city responded by investing over $1 billion to expand its TB control program, increasing staffing to over 600 people to address the more than 3,000 cases diagnosed annually. As a result, local cases decreased into the hundreds, leading to a reduction in funding and resources.
However, since 2014, funding for TB control in New York City has been slashed by over 50%, leaving the city's TB control program with a budget of around $23 million and staffing levels that have declined to 151 personnel. The scarcity of resources and manpower has left the remaining healthcare workforce burdened with heavy caseloads due to the time-sensitive and lengthy treatment process required for TB cases.
Factors Contributing to the Resurgence
Several critical factors have contributed to the resurgence of TB in New York City:
-COVID-19 Pandemic: The COVID-19 pandemic disrupted public health efforts, including TB diagnosis and treatment. People avoided healthcare facilities and testing centers, leading to a decrease in TB diagnoses. As COVID-19 restrictions eased, TB cases began to rise again, contributing to the current surge.
-Migrant Influx: Since spring 2022, New York City has seen an influx of over 100,000 migrants, many of whom live in crowded and poorly-ventilated conditions. These conditions are conducive to the rapid spread of TB, making this population more susceptible to infection.
-Vaccine Fatigue: Vaccine hesitancy and pandemic-related "COVID fatigue" have hampered efforts to control the spread of infectious diseases. This has the potential to exacerbate the TB resurgence.
-Healthcare Infrastructure: Years of budget cuts and staffing shortages have weakened the city's healthcare infrastructure, making it ill-prepared to handle a widespread TB outbreak. Long waits for testing and treatment are common at the city's TB clinics.
-Clinic Closures: The closure of the Washington Heights TB clinic, the only one in Manhattan, has further strained resources, leaving active TB patients with longer waits for treatment and increasing the risk of transmission.
Global Implications of the TB Resurgence
The resurgence of TB in New York City is not an isolated event. It is indicative of a broader trend of increasing TB rates both within the United States and globally. According to data from the Centers for Disease Control and Prevention (CDC), the rate of TB in the United States rose to 2.5 cases per 100,000 people in 2022, up from 2.4 per 100,000 in 2021. This reversal of the decline in TB rates can be attributed to a reduction in testing and delayed diagnoses during the COVID-19 pandemic.
Globally, the World Health Organization (WHO) has issued warnings about the resurgence of TB cases. This marks a significant departure from the two-decade-long decline in TB cases. While TB has been relatively scarce in developed countries, this resurgence underscores the disease's persistent threat, especially in regions with limited access to healthcare, malnutrition, poverty, and overcrowding.
The Impact on Vulnerable Populations
One of the most troubling aspects of the TB resurgence is its impact on vulnerable populations, both in New York City and worldwide. The disease disproportionately affects individuals with weakened immune systems, such as those living with HIV/AIDS. These individuals are at a higher risk of developing active TB infections, which can be life-threatening.
In low-income countries in Africa and Asia, where access to healthcare and medication is limited, TB remains a significant public health challenge. The prognosis for individuals in these regions is often grim, with many unable to access treatment. Shockingly, 96% of children who die from TB never receive treatment.

The Role of Vaccination
Vaccination has historically played a crucial role in the control and prevention of infectious diseases. The Bacillus Calmette-Guérin (BCG) vaccine, specifically developed to combat TB, has been instrumental in reducing TB cases in some parts of the world. However, the BCG vaccine is rarely administered in developed countries where TB has been largely controlled.
Despite this, officials and experts are warning that the threat posed by TB could slowly rise, especially in the aftermath of the COVID-19 pandemic. This underscores the importance of maintaining and expanding vaccination programs to ensure that TB remains under control.
The New York City Experience
In New York City, the resurgence of TB cases has caught public health officials off guard. The city's Department of Health has struggled to respond adequately to the increasing caseloads. Long waits for testing and treatment at the city's TB clinics have become the norm. The closure of the Washington Heights TB clinic, once the only one in Manhattan, has further exacerbated the situation.
City Health Department spokesperson Patrick Gallahue acknowledged the challenges but asserted that the city remained a "leader in TB care." He cited efforts to increase screening, diagnosis, and treatment, along with a contract with a local provider worth up to $500,000 to ensure adequate capacity.
However, healthcare workers on the front lines contend that staffing shortages, especially among doctors, X-ray technicians, case managers, and public health experts, have hampered the city's ability to provide timely care. As a result, patients with active TB often face prolonged wait times for evaluation and treatment, increasing the risk of transmission.
Looking Ahead: The Way Forward
The resurgence of tuberculosis in New York City serves as a sobering reminder of the challenges faced by public health systems, the consequences of underinvestment, and the potential for infectious diseases to rebound when left unattended. Efforts to combat TB require not only enhanced funding and resources but also a renewed commitment to early diagnosis, prompt treatment, and preventive measures.
To address the current TB crisis and prevent future resurgences, several key steps must be taken:
-Increased Funding: Public health officials and policymakers must allocate additional funding to support TB control programs, including staff recruitment, training, and laboratory infrastructure.
-Outreach and Education: Initiatives to raise awareness about TB, its symptoms, and prevention measures must be implemented, targeting both healthcare providers and the general public.
-Improved Testing and Diagnosis: Streamlining the process for TB testing and diagnosis, along with reducing wait times, is essential to prevent further transmission.
-Support for Vulnerable Populations: Efforts should be made to ensure that vulnerable populations, such as migrants and those with compromised immune systems, have access to TB screening and treatment.
-Global Cooperation: TB knows no borders. International cooperation is crucial in the fight against TB, both in terms of research and the equitable distribution of resources and medications.
-Research and Development: Investment in TB research is essential to develop more effective treatments and vaccines and to understand the emergence of drug-resistant strains.
-Public Engagement: Engaging the public in understanding the importance of TB prevention and treatment is crucial to reducing stigma and increasing community support.
The resurgence of tuberculosis in New York City, once a symbol of progress and innovation, serves as a stark reminder of the persistent threat posed by infectious diseases. It highlights the consequences of reduced funding, inadequate resources, and the impact of a global pandemic on public health efforts.
To mitigate the TB crisis in New York City and prevent its escalation, concerted efforts are needed from healthcare authorities, policymakers, and the public. Tuberculosis, once on the verge of elimination, demands renewed attention, investment, and commitment to ensure its containment and eventual eradication. The global community must recognize the interconnectedness of health threats and work collaboratively to address them, for the health and well-being of all.
For the latest Tuberculosis-TB News, keep on logging to Thailand Medical News.


Jun 10, 2023  6 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news